Orange Book product · Brand (NDA)
AROMASIN
EXEMESTANE
At a glance
Oct 21, 1999
Approved
Brand (NDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 21, 1999
27 yr 1 mo ago
Today
Pharmaceutical detail
Active ingredient
EXEMESTANE
Strength
25MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
NDA 020753
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2022EXEMESTANEGeneric (ANDA)
ANDA 216454 · EUGIA PHARMA
- 2020EXEMESTANEGeneric (ANDA)
ANDA 213547 · QILU
- 2019EXEMESTANEGeneric (ANDA)
ANDA 208764 · DR REDDYS LABS SA
- 2019EXEMESTANEGeneric (ANDA)
ANDA 211031 · BRECKENRIDGE
- 2018EXEMESTANEGeneric (ANDA)
ANDA 206421 · AMNEAL PHARMS
- 2018EXEMESTANEGeneric (ANDA)
ANDA 202602 · ZYDUS PHARMS
- 2018EXEMESTANEGeneric (ANDA)
ANDA 210323 · CIPLA
- 2017EXEMESTANEGeneric (ANDA)
ANDA 209208 · UPSHER SMITH LABS
- 2017EXEMESTANEGeneric (ANDA)
ANDA 203315 · RISING
- 2014EXEMESTANEGeneric (ANDA)
ANDA 200898 · ALVOGEN
- 2011EXEMESTANEGeneric (ANDA)
ANDA 077431 · HIKMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
